Aurora Funds: Funding, Team & Investors | Startup Intros

Loading organizations...

Aurora Funds: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 20, 2013	Argos Therapeutics	$17.5M Series E Extension	—	Forbion, Green Cross Holdings, Intersouth Partners, Lumira Ventures, Morningside, Pharmstandard International, TVM Capital
Aug 28, 2013	Argos Therapeutics	$42.5M Series E	Alexandr Shuster	Forbion, Green Cross Holdings, Intersouth Partners, Lumira Ventures, Morningside, TVM Capital
Dec 1, 2012	Regado Biosciences	$51.0M Series E	RusnanoMedInvest	Domain Associates, Baxter Ventures, Caxton Advantage, Quaker Partners
Nov 1, 2012	Cardioxyl Pharmaceuticals	$28.0M Series B	OrbiMed	Jazz Venture Partners, Osage University Partners, Pioneer Fund, New Enterprise Associates
Apr 24, 2012	Argos Therapeutics	$25.0M Series D	Forbion	Intersouth Partners, Lumira Ventures, Morningside, TVM Capital
Aug 29, 2011	Metabolon	$13.1M Series D	—	Fletcher Spaght Ventures, Fulcrum Financial Partners, Harris & Harris Group, Tim Keating, Sevin Rosen Funds, Syngenta Ventures
Apr 1, 2011	Digitalsmiths	$13.0M Series C	Technicolor	.406 Ventures, Innova Memphis, CBC New Media Group, Chrysalis Ventures, Cisco
Aug 3, 2010	Cardioxyl Pharmaceuticals	$15.0M Other Equity	—	New Enterprise Associates
Dec 1, 2009	Regado Biosciences	$40.0M Series D	—	Domain Associates, Caxton Advantage, Quaker Partners
Oct 22, 2009	Centice	$6.1M Series C	Aurora Funds, Innovation Ventures, S-Group Direct Investments	Fulcrum Financial Group
Nov 1, 2008	Digitalsmiths	$12.0M Series B	—	.406 Ventures, Innova Memphis, Chrysalis Ventures